Reverse DCF
What growth does the market imply for EMCURE?
Working backwards from the current price to find the FCF growth assumption baked in.
aggressive
17.1% implied annual FCF growth
The market is pricing in above-average growth. Achievable for a high-quality business but leaves limited margin for error — any slowdown could hurt the price.
Current Price
₹1,608
Historical Growth
12.4%
FCF Yield
3.37%
Price / FCF
29.7x
Plain English
To justify today's price of $1607.70, EMCURE.NS needs to grow its free cash flow at 17.1% per year for the next 10 years. That is 4.7% faster than its historical growth rate of 12.4%. This is optimistic but not impossible for a high-quality business. The stock leaves little room for error — any slowdown could hurt the price.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 8.6% | ₹834 | -48.1% |
| GDP rate | 10.0% | ₹934 | -41.9% |
| Historical | 12.4% | ₹1,128 | -29.9% |
| Implied | 17.1% | ₹1,619 | +0.7% |
At Historical Growth Rate
It would take 20 years for EMCURE to organically grow into today's price assuming its historical FCF growth of 12.4%.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.